“Characteristic of CD4+CD25+ T Cells in Chronic Myeloid Leukemia Patients Treated With Imatinib Mesylate With Different BCR-ABL Transcripts Levels Response”. Medico Legal Update, vol. 21, no. 1, Jan. 2021, pp. 949-55, https://doi.org/10.37506/mlu.v21i1.2438.